Devyser Diagnostics has announced the completion of a private placement of 7,465 shares, corresponding to SEK 130 million before issuance costs, to Swedbank Robur and the Fourth Swedish National Pension Fund (AP4).
The purpose of the issue is primarily to finance the company’s global marketing and sales expansion.
As part of the private placement, Swedbank Robur and AP4 subscribed for shares valued at SEK 80 million and SEK 50 million, respectively. Following the issue, they will hold 12 percent and 8 percent, respectively, of the total number of shares and voting rights in the company becoming the company’s second and fifth largest owners.
“Allows us to increase our global growth initiatives”
“We are proud to attract such highly reputed and capable investors as Swedbank Robur and AP4. This provides a clear mark of quality and validation of the company and our products,” says Fredrik Alpsten, CEO of Devyser Diagnostics. “We believe we are just starting what could be a very favorable expansion of our business. The issue is an important milestone for Devyser and allows us to increase our global growth initiatives and invest in the further development of our product portfolio.”
“We are very impressed by Devyser’s success to date. The company has demonstrated stable and profitable growth for several years and we are convinced that the increased funding will enable the already successful journey not only to continue but also accelerate. We now look forward to following the company as an owner,” says Henrik Carlman, Fund Manager at Swedbank Robur.